All Posts: News Release
-
FDA Approved Drug Extends Survival for Patients with Rare Cancer
WASHINGTON — Sunitinib, an agent approved for use in several cancers, provides unprecedented antitumor activity in thymic carcinoma, a rare but aggressive tumor of the thymus gland, according to a phase II clinical trial led by a researcher at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Orphan Receptor Proteins Deliver Two Knock-out Punches to Glioblastoma Cells
WASHINGTON — Two related proteins exert a lethal double whammy effect against glioblastoma cells when activated with a small molecule, say researchers at Georgetown Lombardi Comprehensive Cancer Center.
Category: News Release
-
Two Georgetown University Medical Center Researchers Named National Academy of Inventors Fellows
WASHINGTON — Two Georgetown University Medical Center researchers have been named 2014 Fellows of the National Academy of Inventors (NAI): —Richard Schlegel, MD, PhD, Oscar B. Hunter Chair of Pathology, and Anatoly Dritschilo, MD, chair of radiation medicine.
Category: News Release
-
Cancer Center Director Delivers Remarks at Cancer Briefing on Capitol Hill
WASHINGTON — Georgetown Lombard Comprehensive Cancer Center Director Louis M. Weiner, MD, participated in a Senate Cancer Coalition panel and briefing on Capitol Hill Dec. 10. Panel co-chairs Sen. Dianne Feinstein and Sen. Johnny Isakson hosted the event. The briefing was led by Harold Varmus, MD, director of the National Cancer Institute, and sponsored by One Voice Against Cancer Coalition.
Category: News Release
-
Time Chooses “The Ebola Fighters” As Its “Person of the Year;” GUMC honors Ebola caregiver Dr. Daniel Lucey
WASHINGTON — Time has selected the “The Ebola Fighters” as the 2014 Person of the Year. Georgetown University Medical Center applauds this selection and honors one of its own Ebola fighters, Daniel Lucey, MD, MPH.
Category: News Release
-
Novel fMRI Technique Identifies HIV-Associated Cognitive Decline Before Symptoms Occur
WASHINGTON — A five-minute functional MRI (fMRI) test can pick up neuronal dysfunction in HIV-positive individuals who don’t yet exhibit cognitive decline, say neuroscientists and clinicians at Georgetown University Medical Center.
Category: News Release
-
Common Chemotherapy Is Not Heart Toxic in Patients With BRCA1/2 Mutations
SAN ANTONIO — Use of anthracycline-based chemotherapy, a common treatment for breast cancer, has negligible cardiac toxicity in women whose tumors have BRCA1/2 mutations — despite preclinical evidence that such treatment can damage the heart.
Category: News Release
-
Agent Prevents Prostate Cancer Growth and Spread in Animal Studies
WASHINGTON — Researchers at Georgetown Lombardi Comprehensive Cancer Center have completed a critical step in the journey from a basic science discovery in the lab to a potential clinical application, showing that an experimental agent prevents tumor growth and spread in mice with prostate cancer harboring a common chromosomal abnormality.
Category: News Release
-
Family Planning Programs Involving Men, Empower Women
WASHINGTON—In a society where women often lead very restricted lives and men are the primary household decision makers, new research suggests women are empowered when men are included in family planning programs. A study, from the Institute for Reproductive Health at Georgetown University Medical Center, suggests that addressing the dynamics between husbands and wives can result in women making more financial decisions and having more control over their social interactions, while at the same time meeting their family planning needs.
Category: News Release
-
‘Not Just a Flavoring’: Menthol and Nicotine, Combined, Desensitize Airway Receptors
Menthol acts in combination with nicotine to desensitize receptors in lungs’ airways that are responsible for nicotine’s irritation, say neuroscientists at Georgetown University Medical Center (GUMC).
Category: News Release